Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 178 entries
Sorted by: Best Match Show Resources per page
Formulation and In-vitro Evaluation of Tretinoin Microemulsion as a Potential Carrier for Dermal Drug Delivery.

Iranian journal of pharmaceutical research : IJPR

Mortazavi SA, Pishrochi S, Jafari Azar Z.
PMID: 24523740
Iran J Pharm Res. 2013;12(4):599-609.

In this study, tretinoin microemulsion has been formulated based on phase diagram studies by changing the amounts and proportions of inactive ingredients, such as surfactants, co-surfactants and oils. The effects of these variables have been determined on microemulsion formation,...

Cite
Mortazavi SA, Pishrochi S, Jafari Azar Z. Formulation and In-vitro Evaluation of Tretinoin Microemulsion as a Potential Carrier for Dermal Drug Delivery. Iran J Pharm Res. 2013;12(4):599-609
Mortazavi, S. A., Pishrochi, S., & Jafari Azar, Z. (2013). Formulation and In-vitro Evaluation of Tretinoin Microemulsion as a Potential Carrier for Dermal Drug Delivery. Iranian journal of pharmaceutical research : IJPR, 12(4), 599-609.
Mortazavi, Seyed Alireza, et al. "Formulation and In-vitro Evaluation of Tretinoin Microemulsion as a Potential Carrier for Dermal Drug Delivery." Iranian journal of pharmaceutical research : IJPR vol. 12,4 (2013): 599-609.
Mortazavi SA, Pishrochi S, Jafari Azar Z. Formulation and In-vitro Evaluation of Tretinoin Microemulsion as a Potential Carrier for Dermal Drug Delivery. Iran J Pharm Res. 2013;12(4):599-609. PMID: 24523740; PMCID: PMC3920698.
Copy Download .nbib Format: NLM
Nevus Comedonicus on Scalp: An Unusual Presentation.

International journal of trichology

Sahu P, Aggrawal K, Bansal C, Jain VK.
PMID: 29440859
Int J Trichology. 2018 Jan-Feb;10(1):37-39. doi: 10.4103/ijt.ijt_71_17.

Nevus comedonicus (NC) is a rare developmental anomaly of follicular infundibulum plugged with keratinous material that resembles comedo-like lesions. Frequently affected sites are face, neck, trunk, and upper arm. Few cases have been described on palms, soles, scalp, and...

Cite
Sahu P, Aggrawal K, Bansal C, et al. Nevus Comedonicus on Scalp: An Unusual Presentation. Int J Trichology. 2018;10(1):37-39doi: 10.4103/ijt.ijt_71_17.
Sahu, P., Aggrawal, K., Bansal, C., & Jain, V. K. (2018). Nevus Comedonicus on Scalp: An Unusual Presentation. International journal of trichology, 10(1), 37-39. https://doi.org/10.4103/ijt.ijt_71_17
Sahu, Priyadarshini, et al. "Nevus Comedonicus on Scalp: An Unusual Presentation." International journal of trichology vol. 10,1 (2018): 37-39. doi: https://doi.org/10.4103/ijt.ijt_71_17
Sahu P, Aggrawal K, Bansal C, Jain VK. Nevus Comedonicus on Scalp: An Unusual Presentation. Int J Trichology. 2018 Jan-Feb;10(1):37-39. doi: 10.4103/ijt.ijt_71_17. PMID: 29440859; PMCID: PMC5803853.
Copy Download .nbib Format: NLM
Regulation of RIC-3 and of nAChR expression.

Oncotarget

Ben-David Y, Treinin M.
PMID: 28086205
Oncotarget. 2017 Jan 24;8(4):5662-5663. doi: 10.18632/oncotarget.13925.

No abstract available.

Cite
Ben-David Y, Treinin M. Regulation of RIC-3 and of nAChR expression. Oncotarget. 2017;8(4):5662-5663doi: 10.18632/oncotarget.13925.
Ben-David, Y., & Treinin, M. (2017). Regulation of RIC-3 and of nAChR expression. Oncotarget, 8(4), 5662-5663. https://doi.org/10.18632/oncotarget.13925
Ben-David, Yael, and Treinin, Millet. "Regulation of RIC-3 and of nAChR expression." Oncotarget vol. 8,4 (2017): 5662-5663. doi: https://doi.org/10.18632/oncotarget.13925
Ben-David Y, Treinin M. Regulation of RIC-3 and of nAChR expression. Oncotarget. 2017 Jan 24;8(4):5662-5663. doi: 10.18632/oncotarget.13925. PMID: 28086205; PMCID: PMC5351569.
Copy Download .nbib Format: NLM
Current treatment options for acanthosis nigricans.

Clinical, cosmetic and investigational dermatology

Patel NU, Roach C, Alinia H, Huang WW, Feldman SR.
PMID: 30122971
Clin Cosmet Investig Dermatol. 2018 Aug 07;11:407-413. doi: 10.2147/CCID.S137527. eCollection 2018.

Acanthosis nigricans (AN) is a common dermatologic manifestation of systemic disease that is associated with insulin resistance, diabetes mellitus, obesity, internal malignancy, endocrine disorders, and drug reactions. Treatment of AN primarily focuses on resolution of the underlying disease processes...

Cite
Patel NU, Roach C, Alinia H, et al. Current treatment options for acanthosis nigricans. Clin Cosmet Investig Dermatol. 2018;11:407-413doi: 10.2147/CCID.S137527.
Patel, N. U., Roach, C., Alinia, H., Huang, W. W., & Feldman, S. R. (2018). Current treatment options for acanthosis nigricans. Clinical, cosmetic and investigational dermatology, 11407-413. https://doi.org/10.2147/CCID.S137527
Patel, Nupur U, et al. "Current treatment options for acanthosis nigricans." Clinical, cosmetic and investigational dermatology vol. 11 (2018): 407-413. doi: https://doi.org/10.2147/CCID.S137527
Patel NU, Roach C, Alinia H, Huang WW, Feldman SR. Current treatment options for acanthosis nigricans. Clin Cosmet Investig Dermatol. 2018 Aug 07;11:407-413. doi: 10.2147/CCID.S137527. eCollection 2018. PMID: 30122971; PMCID: PMC6086114.
Copy Download .nbib Format: NLM
Arsenic Trioxide and Tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL).

Hospital pharmacy

Damery E, Solimando DA, Waddell JA.
PMID: 27698500
Hosp Pharm. 2016 Sep;51(8):628-632. doi: 10.1310/hpj5108-628.

The complexity of cancer chemotherapy requires pharmacists be familiar with the complicated regimens and highly toxic agents used. This column reviews various issues related to preparation, dispensing, and administration of antineoplastic therapy, and the agents, both commercially available and...

Cite
Damery E, Solimando DA, Waddell JA. Arsenic Trioxide and Tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL). Hosp Pharm. 2016;51(8):628-632doi: 10.1310/hpj5108-628.
Damery, E., Solimando, D. A., & Waddell, J. A. (2016). Arsenic Trioxide and Tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL). Hospital pharmacy, 51(8), 628-632. https://doi.org/10.1310/hpj5108-628
Damery, Erin, et al. "Arsenic Trioxide and Tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL)." Hospital pharmacy vol. 51,8 (2016): 628-632. doi: https://doi.org/10.1310/hpj5108-628
Damery E, Solimando DA, Waddell JA. Arsenic Trioxide and Tretinoin (AsO/ATRA) for Acute Promyelocytic Leukemia (APL). Hosp Pharm. 2016 Sep;51(8):628-632. doi: 10.1310/hpj5108-628. PMID: 27698500; PMCID: PMC5030872.
Copy Download .nbib Format: NLM
Topical tretinoin in acanthosis nigricans.

Indian journal of dermatology, venereology and leprology

Lahiri K, Malakar S.
PMID: 20948022
Indian J Dermatol Venereol Leprol. 1996 May-Jun;62(3):159-61.

Efficacy of topical tretinoin was assessed in 30 cases of idiopathic acanthosis nigricans which were recalcitrant to conventional modalities of treatment. Topical tretinoin once at night application was found to be very effective both clinically and histologically.

Cite
Lahiri K, Malakar S. Topical tretinoin in acanthosis nigricans. Indian J Dermatol Venereol Leprol. 1996;62(3):159-61
Lahiri, K., & Malakar, S. (1996). Topical tretinoin in acanthosis nigricans. Indian journal of dermatology, venereology and leprology, 62(3), 159-61.
Lahiri, K, and Malakar, S. "Topical tretinoin in acanthosis nigricans." Indian journal of dermatology, venereology and leprology vol. 62,3 (1996): 159-61.
Lahiri K, Malakar S. Topical tretinoin in acanthosis nigricans. Indian J Dermatol Venereol Leprol. 1996 May-Jun;62(3):159-61. PMID: 20948022.
Copy Download .nbib Format: NLM
Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems.

Pharmaceutics

Latter G, Grice JE, Mohammed Y, Roberts MS, Benson HAE.
PMID: 31554188
Pharmaceutics. 2019 Sep 24;11(10). doi: 10.3390/pharmaceutics11100490.

Acne vulgaris is a common inflammatory pilosebaceous condition that affects 80-90% of adolescents. Since the introduction of tretinoin over 40 years ago, topical retinoid products have been a mainstay of acne treatment. The retinoids are very effective in addressing...

Cite
Latter G, Grice JE, Mohammed Y, et al. Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems. Pharmaceutics. 2019;11(10)doi: 10.3390/pharmaceutics11100490.
Latter, G., Grice, J. E., Mohammed, Y., Roberts, M. S., & Benson, H. A. E. (2019). Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems. Pharmaceutics, 11(10), . https://doi.org/10.3390/pharmaceutics11100490
Latter, Gemma, et al. "Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems." Pharmaceutics vol. 11,10 (2019). doi: https://doi.org/10.3390/pharmaceutics11100490
Latter G, Grice JE, Mohammed Y, Roberts MS, Benson HAE. Targeted Topical Delivery of Retinoids in the Management of Acne Vulgaris: Current Formulations and Novel Delivery Systems. Pharmaceutics. 2019 Sep 24;11(10). doi: 10.3390/pharmaceutics11100490. PMID: 31554188; PMCID: PMC6835300.
Copy Download .nbib Format: NLM
Artificial Optogenetic TRN Stimulation of .

Bio-protocol

Rabinowitch I, Treinin M, Bai J.
PMID: 29170746
Bio Protoc. 2016 Oct 20;6(20). doi: 10.21769/BioProtoc.1966.

Optogenetics is a powerful tool for manipulating neuronal activity with high temporal and spatial precision. In the nematode

Cite
Rabinowitch I, Treinin M, Bai J. Artificial Optogenetic TRN Stimulation of . Bio Protoc. 2016;6(20)doi: 10.21769/BioProtoc.1966.
Rabinowitch, I., Treinin, M., & Bai, J. (2016). Artificial Optogenetic TRN Stimulation of . Bio-protocol, 6(20), . https://doi.org/10.21769/BioProtoc.1966
Rabinowitch, Ithai, et al. "Artificial Optogenetic TRN Stimulation of ." Bio-protocol vol. 6,20 (2016). doi: https://doi.org/10.21769/BioProtoc.1966
Rabinowitch I, Treinin M, Bai J. Artificial Optogenetic TRN Stimulation of . Bio Protoc. 2016 Oct 20;6(20). doi: 10.21769/BioProtoc.1966. PMID: 29170746; PMCID: PMC5697792.
Copy Download .nbib Format: NLM
Nanoscale Mapping and Spectroscopy of Nonradiative Hyperbolic Modes in Hexagonal Boron Nitride Nanostructures.

Nano letters

Brown LV, Davanco M, Sun Z, Kretinin A, Chen Y, Matson JR, Vurgaftman I, Sharac N, Giles AJ, Fogler MM, Taniguchi T, Watanabe K, Novoselov KS, Maier SA, Centrone A, Caldwell JD.
PMID: 29451802
Nano Lett. 2018 Mar 14;18(3):1628-1636. doi: 10.1021/acs.nanolett.7b04476. Epub 2018 Feb 21.

The inherent crystal anisotropy of hexagonal boron nitride (hBN) provides the ability to support hyperbolic phonon polaritons, that is, polaritons that can propagate with very large wave vectors within the material volume, thereby enabling optical confinement to exceedingly small...

Cite
Brown LV, Davanco M, Sun Z, et al. Nanoscale Mapping and Spectroscopy of Nonradiative Hyperbolic Modes in Hexagonal Boron Nitride Nanostructures. Nano Lett. 2018;18(3):1628-1636doi: 10.1021/acs.nanolett.7b04476.
Brown, L. V., Davanco, M., Sun, Z., Kretinin, A., Chen, Y., Matson, J. R., Vurgaftman, I., Sharac, N., Giles, A. J., Fogler, M. M., Taniguchi, T., Watanabe, K., Novoselov, K. S., Maier, S. A., Centrone, A., & Caldwell, J. D. (2018). Nanoscale Mapping and Spectroscopy of Nonradiative Hyperbolic Modes in Hexagonal Boron Nitride Nanostructures. Nano letters, 18(3), 1628-1636. https://doi.org/10.1021/acs.nanolett.7b04476
Brown, Lisa V, et al. "Nanoscale Mapping and Spectroscopy of Nonradiative Hyperbolic Modes in Hexagonal Boron Nitride Nanostructures." Nano letters vol. 18,3 (2018): 1628-1636. doi: https://doi.org/10.1021/acs.nanolett.7b04476
Brown LV, Davanco M, Sun Z, Kretinin A, Chen Y, Matson JR, Vurgaftman I, Sharac N, Giles AJ, Fogler MM, Taniguchi T, Watanabe K, Novoselov KS, Maier SA, Centrone A, Caldwell JD. Nanoscale Mapping and Spectroscopy of Nonradiative Hyperbolic Modes in Hexagonal Boron Nitride Nanostructures. Nano Lett. 2018 Mar 14;18(3):1628-1636. doi: 10.1021/acs.nanolett.7b04476. Epub 2018 Feb 21. PMID: 29451802; PMCID: PMC6140337.
Copy Download .nbib Format: NLM
Topical Treatment of Truncal Acne with Tretinoin Lotion 0.05% and Azelaic Acid Foam.

Case reports in dermatological medicine

St Surin-Lord S, Miller J.
PMID: 32257457
Case Rep Dermatol Med. 2020 Mar 16;2020:5217567. doi: 10.1155/2020/5217567. eCollection 2020.

Truncal acne is present in approximately half of all patients with facial acne but is also occasionally seen in isolation. Important considerations when selecting treatment options for adult female acne, whether on the face, back, chest, or shoulders, include...

Cite
St Surin-Lord S, Miller J. Topical Treatment of Truncal Acne with Tretinoin Lotion 0.05% and Azelaic Acid Foam. Case Rep Dermatol Med. 2020;2020:5217567doi: 10.1155/2020/5217567.
St Surin-Lord, S., & Miller, J. (2020). Topical Treatment of Truncal Acne with Tretinoin Lotion 0.05% and Azelaic Acid Foam. Case reports in dermatological medicine, 20205217567. https://doi.org/10.1155/2020/5217567
St Surin-Lord, Sharleen, and Miller, Judi. "Topical Treatment of Truncal Acne with Tretinoin Lotion 0.05% and Azelaic Acid Foam." Case reports in dermatological medicine vol. 2020 (2020): 5217567. doi: https://doi.org/10.1155/2020/5217567
St Surin-Lord S, Miller J. Topical Treatment of Truncal Acne with Tretinoin Lotion 0.05% and Azelaic Acid Foam. Case Rep Dermatol Med. 2020 Mar 16;2020:5217567. doi: 10.1155/2020/5217567. eCollection 2020. PMID: 32257457; PMCID: PMC7102415.
Copy Download .nbib Format: NLM
Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress.

iScience

Nourse JB, Harshefi G, Marom A, Karmi A, Cohen Ben-Ami H, Caldwell KA, Caldwell GA, Treinin M.
PMID: 33665559
iScience. 2021 Feb 04;24(3):102140. doi: 10.1016/j.isci.2021.102140. eCollection 2021 Mar 19.

Tobacco smoking is a risk factor for several human diseases. Conversely, smoking also reduces the prevalence of Parkinson's disease, whose hallmark is degeneration of

Cite
Nourse JB, Harshefi G, Marom A, et al. Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress. iScience. 2021;24(3):102140doi: 10.1016/j.isci.2021.102140.
Nourse, J. B., Harshefi, G., Marom, A., Karmi, A., Cohen Ben-Ami, H., Caldwell, K. A., Caldwell, G. A., & Treinin, M. (2021). Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress. iScience, 24(3), 102140. https://doi.org/10.1016/j.isci.2021.102140
Nourse, J Brucker, et al. "Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress." iScience vol. 24,3 (2021): 102140. doi: https://doi.org/10.1016/j.isci.2021.102140
Nourse JB, Harshefi G, Marom A, Karmi A, Cohen Ben-Ami H, Caldwell KA, Caldwell GA, Treinin M. Conserved nicotine-activated neuroprotective pathways involve mitochondrial stress. iScience. 2021 Feb 04;24(3):102140. doi: 10.1016/j.isci.2021.102140. eCollection 2021 Mar 19. PMID: 33665559; PMCID: PMC7900352.
Copy Download .nbib Format: NLM
Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin.

Dermatology and therapy

Nahm WJ, Gwillim EC, Badiavas EV, Nichols AJ, Kirsner RS, Boggeln LH, Shen JT.
PMID: 33458805
Dermatol Ther (Heidelb). 2021 Feb;11(1):307-314. doi: 10.1007/s13555-020-00473-w. Epub 2021 Jan 17.

The recent coronavirus disease 2019 (COVID-19) pandemic has created a quandary for the physician in terms of evaluating and treating cutaneous skin cancers, particularly melanomas. At the onset of the pandemic, many planned medical and surgical visits for skin...

Cite
Nahm WJ, Gwillim EC, Badiavas EV, et al. Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin. Dermatol Ther (Heidelb). 2021;11(1):307-314doi: 10.1007/s13555-020-00473-w.
Nahm, W. J., Gwillim, E. C., Badiavas, E. V., Nichols, A. J., Kirsner, R. S., Boggeln, L. H., & Shen, J. T. (2021). Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin. Dermatology and therapy, 11(1), 307-314. https://doi.org/10.1007/s13555-020-00473-w
Nahm, William J, et al. "Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin." Dermatology and therapy vol. 11,1 (2021): 307-314. doi: https://doi.org/10.1007/s13555-020-00473-w
Nahm WJ, Gwillim EC, Badiavas EV, Nichols AJ, Kirsner RS, Boggeln LH, Shen JT. Treating Melanoma in Situ During a Pandemic with Telemedicine and a Combination of Imiquimod, 5-Fluorouracil, and Tretinoin. Dermatol Ther (Heidelb). 2021 Feb;11(1):307-314. doi: 10.1007/s13555-020-00473-w. Epub 2021 Jan 17. PMID: 33458805; PMCID: PMC7811867.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 178 entries